Joseph Brandwein

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

Medicine, Molecular Medicine, Pharmacotherapy +16

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

Liran I. Shlush, Sasan Zandi, Amanda Mitchell et al. · Nature · 2014 · 1.4K citations · Full text

Life Sciences, Cell Biology, Hematology +14

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

Stephen H. Petersdorf, Kenneth J. Kopecky, Marilyn L. Slovak et al. · Blood · 2013 · 633 citations

Medicine, Hematology, Pharmacology +10

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Eric J. Feldman, Joseph Brandwein, Richard M. Stone et al. · Journal of Clinical Oncology · 2005 · 249 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Hartmut Döhner, Michael Lübbert, Walter Fiedler et al. · Blood · 2014 · 229 citations · Full text

Medicine, Pharmacology, Chemotherapy +9